Serum immune responses predict rapid disease progression among children with Crohn's disease: Immune responses predict disease progression

被引:198
作者
Dubinsky, MC
Lin, YC
Dutridge, D
Picornell, Y
Landers, CJ
Farrior, S
Wrobel, I
Quiros, A
Vasiliauskas, EA
Grill, B
Israel, D
Bahar, R
Christie, D
Wahbeh, G
Silber, G
Dallazadeh, S
Shah, P
Thomas, D
Kelts, D
Hershberg, RM
Elson, CO
Targan, SR
Taylor, KD
Rotter, JI
Yang, HY
机构
[1] Cedars Sinai Med Ctr, Dept Pediat, Med & Med Genet Inst, Los Angeles, CA 90048 USA
[2] Western Reg Pediat IBD Res Alliance, Dept Pediat, Calgary, AB, Canada
[3] Alberta Childrens Prov Gen Hosp, Dept Pediat, Calgary, AB, Canada
[4] Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA
[5] BC Childrens Hosp, Dept Pediat, Vancouver, BC, Canada
[6] Kaiser Permanente So Calif, Dept Pediat, San Diego, CA USA
[7] Seattle Childrens Hosp, Dept Pediat, Seattle, WA USA
[8] Phoenix Childrens Hosp, Dept Pediat, Phoenix, AZ USA
[9] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA
[10] Childrens Hosp So Calif, Dept Pediat, Fresno, CA USA
[11] Dendreon Corp, Dept Pediat, Seattle, WA USA
[12] Univ Alabama Birmingham, Div Gastroenterol, Dept Pediat, Birmingham, AL 35294 USA
关键词
D O I
10.1111/j.1572-0241.2006.00456.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND AND AIM: Crohn's disease (CD) is a heterogeneous disorder characterized by diverse clinical phenotypes. Childhood-onset CD has been described as a more aggressive phenotype. Genetic and immune factors may influence disease phenotype and clinical course. We examined the association of immune responses to microbial antigens with disease behavior and prospectively determined the influence of immune reactivity on disease progression in pediatric CD patients. METHODS: Sera were collected from 196 pediatric CD cases and tested for immune responses: anti-I2, anti-outer membrane protein C (anti-OmpC), anti-CBir1 flagellin (anti-CBir1), and anti-Saccharomyces-cerevisiae (ASCA) using ELISA. Associations between immune responses and clinical phenotype were evaluated. RESULTS: Fifty-eight patients (28%) developed internal penetrating and/or stricturing (IP/S) disease after a median follow-up of 18 months. Both anti-OmpC (p < 0.0006) and anti-I2 (p < 0.003) were associated with IP/S disease. The frequency of IP/S disease increased with increasing number of immune responses (p trend = 0.002). The odds of developing IP/S disease were highest in patients positive for all four immune responses (OR (95% CI): 11 (1.5-80.4); p= 0.03). Pediatric CD patients positive for >= 1 immune response progressed to IP/S disease sooner after diagnosis as compared to those negative for all immune responses (p < 0.03). CONCLUSIONS: The presence and magnitude of immune responses to microbial antigens are significantly associated with more aggressive disease phenotypes among children with CD. This is the first study to prospectively demonstrate that the time to develop a disease complication in children is significantly faster in the presence of immune reactivity, thereby predicting disease progression to more aggressive disease phenotypes among pediatric CD patients.
引用
收藏
页码:360 / 367
页数:8
相关论文
共 23 条
[1]   Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease [J].
Abreu, MT ;
Taylor, KD ;
Lin, YC ;
Hang, T ;
Gaiennie, J ;
Landers, CJ ;
Vasiliauskas, EA ;
Kam, LY ;
Rojany, M ;
Papadakis, KA ;
Rotter, JI ;
Targan, SR ;
Yang, HY .
GASTROENTEROLOGY, 2002, 123 (03) :679-688
[2]   The molecular classification of the clinical manifestations of Crohn's disease [J].
Ahmad, T ;
Armuzzi, A ;
Bunce, M ;
Mulcahy-Hawes, K ;
Marshall, SE ;
Orchard, TR ;
Crawshaw, J ;
Large, O ;
De Silva, A ;
Cook, JT ;
Barnardo, M ;
Cullen, S ;
Welsh, KI ;
Jewell, DP .
GASTROENTEROLOGY, 2002, 122 (04) :854-866
[3]   Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype [J].
Arnott, IDR ;
Landers, CJ ;
Nimmo, EJ ;
Drummond, HE ;
Smith, BKR ;
Targan, SR ;
Satsangi, J .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2376-2384
[4]   Clinical characteristics of Crohn's disease in 72 families [J].
Colombel, JF ;
Grandbastien, B ;
GowerRousseau, C ;
Plegat, S ;
Evrard, JP ;
Dupas, JL ;
Gendre, JP ;
Modigliani, R ;
Belaiche, J ;
Hostein, J ;
Hugot, JP ;
VanKruiningen, H ;
Cortot, A .
GASTROENTEROLOGY, 1996, 111 (03) :604-607
[5]   Long-term evolution of disease behavior of Crohn's disease [J].
Cosnes, J ;
Cattan, S ;
Blain, A ;
Beaugerie, L ;
Carbonnel, F ;
Parc, R ;
Gendre, JP .
INFLAMMATORY BOWEL DISEASES, 2002, 8 (04) :244-250
[6]   The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease [J].
Cuthbert, AP ;
Fisher, SA ;
Mirza, MM ;
King, K ;
Hampe, J ;
Croucher, PJP ;
Mascheretti, S ;
Sanderson, J ;
Forbes, A ;
Mansfield, J ;
Schreiber, S ;
Lewis, CM ;
Mathew, CG .
GASTROENTEROLOGY, 2002, 122 (04) :867-874
[7]   Utility of Serum Antibodies in Determining Clinical Course in Pediatric Crohn's Disease [J].
Desir, Barbara ;
Amre, Devendra K. ;
Lu, Shou-En ;
Ohman-Strickland, Pamela ;
Dubinsky, Marla ;
Fisher, Rachel ;
Seidman, Ernest G. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (02) :139-146
[8]   A simple classification of Crohn's disease: Report of the Working Party for the world congresses of gastroenterology, Vienna 1998 [J].
Gasche, C ;
Scholmerich, J ;
Brynskov, J ;
D'Haens, G ;
Hanauer, SB ;
Irvine, EJ ;
Jewell, DP ;
Rachmilewitz, D ;
Sachar, DB ;
Sandborn, WJ ;
Sutherland, LR .
INFLAMMATORY BOWEL DISEASES, 2000, 6 (01) :8-15
[9]   Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease [J].
Hugot, JP ;
Chamaillard, M ;
Zouali, H ;
Lesage, S ;
Cézard, JP ;
Belaiche, J ;
Almer, S ;
Tysk, C ;
O'Morain, CA ;
Gassull, M ;
Binder, V ;
Finkel, Y ;
Cortot, A ;
Modigliani, R ;
Laurent-Puig, P ;
Gower-Rousseau, C ;
Macry, J ;
Colombel, JF ;
Sahbatou, M ;
Thomas, G .
NATURE, 2001, 411 (6837) :599-603
[10]   Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria [J].
Kim, SC ;
Tonkonogy, SL ;
Albright, CA ;
Tsang, J ;
Balish, EJ ;
Braun, J ;
Huycke, MM ;
Sartor, RB .
GASTROENTEROLOGY, 2005, 128 (04) :891-906